Skip to main navigation Skip to search Skip to main content

Magnetic resonance imaging (MRI) in evaluating in vivo response to neoadjuvant chemotherapy for osteosarcomas of the extremities

  • W. R. Hogeboom
  • , H. J. Hoekstra
  • , E. L. Mooyaart
  • , J. W. Oosterhuis
  • , A. Postma
  • , R. P.H. Veth
  • , H. Schraffordt Koops

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Limb-saving procedures for patients with osteosarcomas of the extremities are based on the anatomical localization and extent of the tumor. The effectivenss of neoadjuvant chemotherapy, high-dose methotrexate (HD MTX), was prospectively analyzed in patients using magnetic resonance imaging (MRI) and histologic evaluation of bone biopsies. Evaluation of in vivo rsponse to neoadjuvant chemotherapy for osteosarcomas with MRI is a method which seems promising in predicting the histologic tumor reaction.

Original languageEnglish
Pages (from-to)424-430
Number of pages7
JournalEuropean Journal of Surgical Oncology
Volume15
Issue number5
Publication statusPublished - 1989
Externally publishedYes

Fingerprint

Dive into the research topics of 'Magnetic resonance imaging (MRI) in evaluating in vivo response to neoadjuvant chemotherapy for osteosarcomas of the extremities'. Together they form a unique fingerprint.

Cite this